Dr. Hong Ling 凌泓
Chief Physician
Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical and comprehensive treatment of breast cancer, including mastectomy, modified radical mastectomy, breast-conserving surgery, and breast reconstruction.
Dr. Ling is a Chief Physician and Master’s supervisor with a doctorate in oncology from Fudan University Shanghai Medical College. Since 2003, Dr. Ling has worked in the Breast Surgery Department at Fudan University Shanghai Cancer Center. Clinical training included periods at MD Anderson Cancer Center, UCLA Medical Center, Kwong Wah Hospital, European Cancer Centre, and Stavanger University Hospital. Dr. Ling has led or participated in multiple clinical research projects funded by national and Shanghai municipal agencies.
Professional roles
- Member, Union for International Cancer Control (UICC)
- Expert Reviewer, UICC AUF Panel
- Member, China Anti-Cancer Association
- Reviewer, Asia-Pacific Journal of Clinical Oncology, BMC Cancer, Chinese Journal of Cancer
Name order: in Chinese the family name comes first (Ling Hong). Papers usually list the name as Hong Ling or Ling H.
Selected publications
27 papers on PubMed matched by name and affiliation; 6 as first or senior author since 2016. Most recent first- or senior-author papers:
- BMC Cancer, 2025 (senior author): Retrospective insights: clinical characteristics and survival in 403 ILC cases from China. PubMed 40681988
- Cell Death Dis, 2022 (senior author): HNRNPU promotes the progression of triple-negative breast cancer via RNA transcription and alternative splicing mechanisms. PubMed 36347834
- Cancer Manag Res, 2022 (senior author): Clinical Characteristics and Survival Outcomes of Infiltrating Lobular Carcinoma: A Retrospective Study of 365 Cases in China. PubMed 35210861
- Cancer Manag Res, 2022 (senior author): Clinicopathological Characteristics and Survival Outcomes of Mammary Paget's Disease: A Retrospective Study Based on a Chinese Population. PubMed 35125891
- BMC Cancer, 2020 (senior author): Clinical features and survival of pregnancy-associated breast cancer: a retrospective study of 203 cases in China. PubMed 32293328
- Oncotarget, 2016 (first author): Genetic evaluation of BRCA1 associated a complex genes with triple-negative breast cancer susceptibility in Chinese women. PubMed 26848770
- Asia Pac J Clin Oncol, 2013 (first author): Malignant calcification is an important unfavorable prognostic factor in primary invasive breast cancer. PubMed 22897789
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion